$131.33
3.792.97%
Axsome Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Axsome Therapeutics using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q4 | 2025-02-18 | $-0.80 | $-0.99 | 19.2 % |
Q3 | 2024-11-12 | $-0.49 | $-1.41 | 65.3 % |
Q2 | 2024-08-05 | $-1.12 | $-1.33 | 15.8 % |
Q1 | 2024-05-06 | $-1.00 | $-1.21 | 17.4 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q4 | 2025-02-18 | $118.77M | $117.83M | 0.79 % |
Q3 | 2024-11-12 | $104.76M | $98.10M | 6.79 % |
Q2 | 2024-08-05 | $87.17M | $86.92M | 0.28 % |
Q1 | 2024-05-06 | $75.00M | $73.47M | 2.08 % |
Axsome Therapeutics (AXSM) is scheduled to report earnings on May 5, 2025. The last reported earnings were for reported on February 18, 2025 for Q4.
The Actual EPS was $-0.80, which beat the estimate of $-0.99.
The Actual Revenue was $118.8M, which beat the estimate of $117.8M.
Browse earnings estimates, EPS, and revenue on all stocks.